Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

A radioisotope-nondependent high-sensitivity method for measuring the activity of glioblastoma-related O(6)-methylguanine DNA methyltransferase.

Hongo A, Gu R, Suzuki M, Nemoto N, Nishigaki K.

Anal Biochem. 2015 Jul 1;480:82-4. doi: 10.1016/j.ab.2014.08.012. Epub 2014 Aug 28.

PMID:
25173514
2.

Three cases of struma ovarii underwent laparoscopic surgery with definite preoperative diagnosis.

Nurliza Binti Md Nor, Kusumoto T, Inoue S, Nakamura K, Seki N, Hongo A, Kodama J, Hiramatsu Y.

Acta Med Okayama. 2013;67(3):191-5.

3.

Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.

Kodama J, Fukushima C, Kusumoto T, Nakamura K, Seki N, Hongo A, Hiramatsu Y.

Eur J Gynaecol Oncol. 2013;34(1):39-41.

PMID:
23589998
4.

Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer.

Kodama J, Seki N, Fukushima C, Kusumoto T, Nakamura K, Hongo A, Hiramatsu Y.

Oncol Lett. 2013 Jan;5(1):299-304. Epub 2012 Oct 15.

5.

Changes in soluble fibrin levels during the perioperative period of gynecologic cancer surgery.

Kodama J, Seki N, Fukushima C, Kusumoto T, Nakamura K, Hongo A, Hiramatsu Y.

Oncol Lett. 2012 Nov;4(5):1122-1124. Epub 2012 Aug 31.

6.

Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial).

Nasu K, Satoh T, Nishio S, Nagai Y, Ito K, Otsuki T, Hongo A, Hirashima Y, Ogura T, Shimada M.

Gynecol Oncol. 2013 Feb;128(2):198-203. doi: 10.1016/j.ygyno.2012.11.001. Epub 2012 Nov 8.

PMID:
23142074
7.

The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer.

Nakamura K, Joja I, Fukushima C, Haruma T, Hayashi C, Kusumoto T, Seki N, Hongo A, Hiramatsu Y.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):52-60. doi: 10.1007/s00259-012-2240-7. Epub 2012 Sep 12.

PMID:
22968401
8.

Short communication: effect of difructose anhydride III on serum immunoglobulin G concentration in newborn calves.

Sato T, Hanada M, Ohtani M, Nakai T, Teramura M, Sadoya H, Takahashi T, Hongo A.

J Dairy Sci. 2012 Sep;95(9):5336-9. doi: 10.3168/jds.2011-4989.

PMID:
22916939
9.

The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence.

Nakamura K, Joja I, Nagasaka T, Fukushima C, Kusumoto T, Seki N, Hongo A, Kodama J, Hiramatsu Y.

Gynecol Oncol. 2012 Dec;127(3):478-83. doi: 10.1016/j.ygyno.2012.07.123. Epub 2012 Aug 11.

PMID:
22892362
10.

Role of emmprin in endometrial cancer.

Nakamura K, Kodama J, Hongo A, Hiramatsu Y.

BMC Cancer. 2012 May 28;12:191. doi: 10.1186/1471-2407-12-191.

11.

Anti-angiogenesis effect of 3'-sulfoquinovosyl-1'-monoacylglycerol via upregulation of thrombospondin 1.

Matsuki K, Tanabe A, Hongo A, Sugawara F, Sakaguchi K, Takahashi N, Sato N, Sahara H.

Cancer Sci. 2012 Aug;103(8):1546-52. doi: 10.1111/j.1349-7006.2012.02333.x. Epub 2012 Jun 20.

12.

[I. Uterine cervical neoplasms 2. Strategy for treatment of adenocarcinoma in situ of uterine cervix and the role of chemotherapy ].

Hongo A.

Gan To Kagaku Ryoho. 2012 Feb;39(2):184-9. Review. Japanese. No abstract available.

PMID:
22545284
13.

Antitumor effects of novel shorter truncated insulin-like growth factor I receptors.

Ojima Y, Hongo A, Liu Y, Zhu L, Kusumoto T, Nakamura K, Seki N, Hiramatsu Y.

Cancer Biol Ther. 2012 May;13(7):559-66. doi: 10.4161/cbt.19609. Epub 2012 May 1.

PMID:
22406993
15.

AgI-coated silver-clad stainless steel hollow waveguides for infrared lightwave transmission and their applications.

Hongo A, Sato S, Hattori A, Iwai K, Takaku H, Miyagi M.

Appl Opt. 2012 Jan 1;51(1):1-7. doi: 10.1364/AO.51.000001.

PMID:
22270406
16.

Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.

Mori M, Miyamoto T, Yakushiji H, Ohno S, Miyake Y, Sakaguchi T, Hattori M, Hongo A, Nakaizumi A, Ueda M, Ohno E.

Hum Cell. 2012 Mar;25(1):9-15. doi: 10.1007/s13577-011-0038-8. Epub 2011 Dec 22.

PMID:
22189483
17.

Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Nakamura K, Joja I, Kodama J, Hongo A, Hiramatsu Y.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):283-90. doi: 10.1007/s00259-011-1978-7. Epub 2011 Nov 10.

PMID:
22072286
18.

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.

Nakamura K, Imafuku N, Nishida T, Niwa I, Joja I, Hongo A, Kodama J, Hiramatsu Y.

Gynecol Oncol. 2012 Feb;124(2):335-9. doi: 10.1016/j.ygyno.2011.10.014. Epub 2011 Oct 18.

PMID:
22008707
19.

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

Nakamura K, Hongo A, Kodama J, Hiramatsu Y.

Gynecol Oncol. 2011 Oct;123(1):82-7. doi: 10.1016/j.ygyno.2011.06.026. Epub 2011 Jul 20.

PMID:
21764107
20.

Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.

Kodama J, Kusumoto T, Nakamura K, Seki N, Hongo A, Hiramatsu Y.

Gynecol Oncol. 2011 Sep;122(3):491-4. doi: 10.1016/j.ygyno.2011.05.038. Epub 2011 Jun 24.

PMID:
21703671
Items per page

Supplemental Content

Write to the Help Desk